← Browse by Condition
Medical Condition

endocrine system diseases

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for endocrine system diseases sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — endocrine system diseases Clinical Trials

How many clinical trials are currently recruiting for endocrine system diseases?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for endocrine system diseases, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for endocrine system diseases?
endocrine system diseases research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a endocrine system diseases clinical trial?
Eligibility criteria for endocrine system diseases trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
OncoSil Medical Limited 1 trial
Gaia AG 1 trial
Imperial College London 1 trial
McGill University 1 trial

Recruiting Clinical Trials

NCT04493632
Recruiting

OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.

Enrollment
500 pts
Location
Spain, United Kingdo...
Sponsor
OncoSil Medical Limited
View Trial →
NCT06529965
Recruiting

Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM

Enrollment
250 pts
Location
Germany
Sponsor
Gaia AG
View Trial →
NCT04039763
Recruiting

RT-CGM in Young Adults at Risk of DKA

Enrollment
20 pts
Location
United Kingdom
Sponsor
Imperial College London
View Trial →
NCT07348432
Recruiting

The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes

Enrollment
106 pts
Location
Canada
Sponsor
McGill University
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology